0 XP   0   0   0

Hyloris Developmentsen Sa
Buy, Hold or Sell?

Should you buy, hold or sell Hyloris?

I guess you are interested in Hyloris Developmentsen Sa. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Hyloris

Let's start. I'm going to help you getting a better view of Hyloris Developmentsen Sa. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Hyloris Developmentsen Sa even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Hyloris Developmentsen Sa is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Hyloris Developmentsen Sa. The closing price on 2023-01-27 was €14.64 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Hyloris Developmentsen Sa Daily Candlestick Chart
Hyloris Developmentsen Sa Daily Candlestick Chart
Summary









1. Valuation of Hyloris




Current price per share

€14.64

2. Growth of Hyloris




Is Hyloris growing?

Current yearPrevious yearGrowGrow %
How rich?$52.2m$64.1m-$11.9m-22.9%

How much money is Hyloris making?

Current yearPrevious yearGrowGrow %
Making money-$12.5m-$7.7m-$4.8m-38.3%
Net Profit Margin-374.0%-4,082.9%--

How much money comes from the company's main activities?

3. Financial Health of Hyloris




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  


Richest
#671 / 1232

Most Revenue
#463 / 1232

Most Profit
#652 / 1232

Most Efficient
#839 / 1232


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Hyloris Developmentsen Sa.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hyloris earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Hyloris to the Biotechnology industry mean.
  • A Net Profit Margin of -374.0% means that €-3.74 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hyloris Developmentsen Sa:

  • The MRQ is -374.0%. The company is making a huge loss. -2
  • The TTM is -374.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-374.0%TTM-374.0%0.0%
TTM-374.0%YOY-4,082.9%+3,708.9%
TTM-374.0%5Y-3,694.0%+3,320.0%
5Y-3,694.0%10Y-3,694.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-374.0%-223.6%-150.4%
TTM-374.0%-281.7%-92.3%
YOY-4,082.9%-344.8%-3,738.1%
5Y-3,694.0%-450.1%-3,243.9%
10Y-3,694.0%-541.0%-3,153.0%
1.1.2. Return on Assets

Shows how efficient Hyloris is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hyloris to the Biotechnology industry mean.
  • -18.3% Return on Assets means that Hyloris generated €-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hyloris Developmentsen Sa:

  • The MRQ is -18.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.3%TTM-18.3%0.0%
TTM-18.3%YOY-10.3%-7.9%
TTM-18.3%5Y-55.3%+37.0%
5Y-55.3%10Y-55.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.3%-9.9%-8.4%
TTM-18.3%-8.9%-9.4%
YOY-10.3%-9.3%-1.0%
5Y-55.3%-11.7%-43.6%
10Y-55.3%-12.7%-42.6%
1.1.3. Return on Equity

Shows how efficient Hyloris is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hyloris to the Biotechnology industry mean.
  • -24.1% Return on Equity means Hyloris generated €-0.24 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hyloris Developmentsen Sa:

  • The MRQ is -24.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.1%TTM-24.1%0.0%
TTM-24.1%YOY-12.1%-12.0%
TTM-24.1%5Y-7.2%-16.9%
5Y-7.2%10Y-7.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.1%-12.0%-12.1%
TTM-24.1%-11.5%-12.6%
YOY-12.1%-10.8%-1.3%
5Y-7.2%-14.2%+7.0%
10Y-7.2%-15.2%+8.0%

1.2. Operating Efficiency of Hyloris Developmentsen Sa.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hyloris is operating .

  • Measures how much profit Hyloris makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hyloris to the Biotechnology industry mean.
  • An Operating Margin of -346.4% means the company generated €-3.46  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hyloris Developmentsen Sa:

  • The MRQ is -346.4%. The company is operating very inefficient. -2
  • The TTM is -346.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-346.4%TTM-346.4%0.0%
TTM-346.4%YOY-3,515.4%+3,169.0%
TTM-346.4%5Y-3,409.9%+3,063.5%
5Y-3,409.9%10Y-3,409.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-346.4%-207.3%-139.1%
TTM-346.4%-271.0%-75.4%
YOY-3,515.4%-325.9%-3,189.5%
5Y-3,409.9%-454.0%-2,955.9%
10Y-3,409.9%-537.1%-2,872.8%
1.2.2. Operating Ratio

Measures how efficient Hyloris is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.34 means that the operating costs are €4.34 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Hyloris Developmentsen Sa:

  • The MRQ is 4.342. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.342. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.342TTM4.3420.000
TTM4.342YOY32.869-28.526
TTM4.3425Y35.282-30.940
5Y35.28210Y35.2820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3422.871+1.471
TTM4.3423.504+0.838
YOY32.8693.604+29.265
5Y35.2825.132+30.150
10Y35.2826.371+28.911

1.3. Liquidity of Hyloris Developmentsen Sa.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hyloris is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.60 means the company has €3.60 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Hyloris Developmentsen Sa:

  • The MRQ is 3.603. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.603. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.603TTM3.6030.000
TTM3.603YOY31.244-27.642
TTM3.6035Y7.317-3.714
5Y7.31710Y7.3170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6035.117-1.514
TTM3.6035.755-2.152
YOY31.2445.854+25.390
5Y7.3176.511+0.806
10Y7.3176.222+1.095
1.3.2. Quick Ratio

Measures if Hyloris is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hyloris to the Biotechnology industry mean.
  • A Quick Ratio of 3.56 means the company can pay off €3.56 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hyloris Developmentsen Sa:

  • The MRQ is 3.564. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.564. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.564TTM3.5640.000
TTM3.564YOY30.331-26.767
TTM3.5645Y7.087-3.522
5Y7.08710Y7.0870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5644.284-0.720
TTM3.5644.664-1.100
YOY30.3314.787+25.544
5Y7.0875.218+1.869
10Y7.0875.182+1.905

1.4. Solvency of Hyloris Developmentsen Sa.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hyloris assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hyloris to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.24 means that Hyloris assets are financed with 24.3% credit (debt) and the remaining percentage (100% - 24.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hyloris Developmentsen Sa:

  • The MRQ is 0.243. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.243. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.243TTM0.2430.000
TTM0.243YOY0.146+0.096
TTM0.2435Y1.327-1.084
5Y1.32710Y1.3270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2430.278-0.035
TTM0.2430.277-0.034
YOY0.1460.306-0.160
5Y1.3270.367+0.960
10Y1.3270.403+0.924
1.4.2. Debt to Equity Ratio

Measures if Hyloris is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hyloris to the Biotechnology industry mean.
  • A Debt to Equity ratio of 32.0% means that company has €0.32 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hyloris Developmentsen Sa:

  • The MRQ is 0.320. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.320. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.320TTM0.3200.000
TTM0.320YOY0.171+0.149
TTM0.3205Y0.098+0.222
5Y0.09810Y0.0980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3200.315+0.005
TTM0.3200.317+0.003
YOY0.1710.319-0.148
5Y0.0980.403-0.305
10Y0.0980.462-0.364

2. Market Valuation of Hyloris Developmentsen Sa

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Hyloris generates.

  • Above 15 is considered overpriced but always compare Hyloris to the Biotechnology industry mean.
  • A PE ratio of -41.83 means the investor is paying €-41.83 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hyloris Developmentsen Sa:

  • The EOD is -35.403. Company is losing money. -2
  • The MRQ is -41.835. Company is losing money. -2
  • The TTM is -41.835. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-35.403MRQ-41.835+6.432
MRQ-41.835TTM-41.8350.000
TTM-41.835YOY-37.229-4.606
TTM-41.8355Y-15.813-26.022
5Y-15.81310Y-15.8130.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-35.403-8.986-26.417
MRQ-41.835-9.792-32.043
TTM-41.835-16.243-25.592
YOY-37.229-20.876-16.353
5Y-15.813-16.665+0.852
10Y-15.813-14.732-1.081
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Hyloris.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Hyloris Developmentsen Sa:

  • The MRQ is -110.258. Very Bad. -2
  • The TTM is -110.258. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-110.258TTM-110.2580.000
TTM-110.258YOY-55.549-54.709
TTM-110.2585Y-82.904-27.355
5Y-82.90410Y-82.9040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-110.258-0.032-110.226
TTM-110.2580.004-110.262
YOY-55.5490.016-55.565
5Y-82.9040.006-82.910
10Y-82.9040.003-82.907

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hyloris is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 10.08 means the investor is paying €10.08 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Hyloris Developmentsen Sa:

  • The EOD is 8.530. Seems overpriced? -1
  • The MRQ is 10.080. Seems overpriced? -1
  • The TTM is 10.080. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD8.530MRQ10.080-1.550
MRQ10.080TTM10.0800.000
TTM10.080YOY4.504+5.576
TTM10.0805Y2.917+7.163
5Y2.91710Y2.9170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.5301.835+6.695
MRQ10.0802.006+8.074
TTM10.0802.774+7.306
YOY4.5043.453+1.051
5Y2.9172.713+0.204
10Y2.9172.402+0.515
2. Total Gains per Share

2.4. Latest News of Hyloris Developmentsen Sa

Does Hyloris Developmentsen Sa still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Hyloris Developmentsen Sa to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-01-24
07:00
Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European CountriesRead
2023-01-20
07:00
Hyloris Pharmaceuticals expands its Pipeline with a Product Candidate for a Mineral Deficiency in the Blood (hypophosphatemia)Read

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hyloris Developmentsen Sa compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.393-0.3930%2.473-116%0.343-214%0.343-214%
Book Value Growth--0.8140.8140%7.797-90%2.322-65%2.322-65%
Book Value Per Share--1.7161.7160%2.109-19%0.630+172%0.630+172%
Book Value Per Share Growth--0.8140.8140%7.797-90%2.322-65%2.322-65%
Current Ratio--3.6033.6030%31.244-88%7.317-51%7.317-51%
Debt To Asset Ratio--0.2430.2430%0.146+66%1.327-82%1.327-82%
Debt To Equity Ratio--0.3200.3200%0.171+87%0.098+226%0.098+226%
Dividend Per Share----0%-0%-0%-0%
Eps---0.414-0.4140%-0.255-38%-0.240-42%-0.240-42%
Eps Growth--0.3790.3790%0.670-43%0.525-28%0.525-28%
Free Cash Flow Per Share---0.440-0.4400%-0.185-58%-0.237-46%-0.237-46%
Free Cash Flow Per Share Growth---0.371-0.3710%1.103-134%0.609-161%0.609-161%
Free Cash Flow To Equity Per Share---0.442-0.4420%2.293-119%0.369-220%0.369-220%
Free Cash Flow To Equity Per Share Growth---0.193-0.1930%27.847-101%40.012-100%40.012-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.310--------
Intrinsic Value_10Y_min--6.706--------
Intrinsic Value_1Y_max---0.166--------
Intrinsic Value_1Y_min---0.161--------
Intrinsic Value_3Y_max--0.263--------
Intrinsic Value_3Y_min--0.235--------
Intrinsic Value_5Y_max--1.609--------
Intrinsic Value_5Y_min--1.415--------
Net Profit Margin---3.740-3.7400%-40.829+992%-36.940+888%-36.940+888%
Operating Margin---3.464-3.4640%-35.154+915%-34.099+884%-34.099+884%
Operating Ratio--4.3424.3420%32.869-87%35.282-88%35.282-88%
Pb Ratio8.530-18%10.08010.0800%4.504+124%2.917+246%2.917+246%
Pe Ratio-35.403+15%-41.835-41.8350%-37.229-11%-15.813-62%-15.813-62%
Peg Ratio---110.258-110.2580%-55.549-50%-82.904-25%-82.904-25%
Price Per Share14.640-18%17.30017.3000%9.500+82%5.360+223%5.360+223%
Price To Total Gains Ratio-37.256+15%-44.025-44.0250%3.841-1246%-20.092-54%-20.092-54%
Profit Growth--0.3790.3790%0.670-43%0.641-41%0.641-41%
Quick Ratio--3.5643.5640%30.331-88%7.087-50%7.087-50%
Return On Assets---0.183-0.1830%-0.103-43%-0.553+203%-0.553+203%
Return On Equity---0.241-0.2410%-0.121-50%-0.072-70%-0.072-70%
Revenue Growth--17.69117.6910%1.923+820%5.260+236%5.260+236%
Total Gains Per Share---0.393-0.3930%2.473-116%0.343-214%0.343-214%
Total Gains Per Share Growth---0.159-0.1590%14.095-101%-3.658+2202%-3.658+2202%
Usd Book Value--52232066.40052232066.4000%64191227.100-19%19168568.400+172%19168568.400+172%
Usd Book Value Change Per Share---0.427-0.4270%2.688-116%0.373-214%0.373-214%
Usd Book Value Per Share--1.8651.8650%2.293-19%0.685+172%0.685+172%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.449-0.4490%-0.277-38%-0.261-42%-0.261-42%
Usd Free Cash Flow---13380825.900-13380825.9000%-5644271.700-58%-7197669.180-46%-7197669.180-46%
Usd Free Cash Flow Per Share---0.478-0.4780%-0.202-58%-0.257-46%-0.257-46%
Usd Free Cash Flow To Equity Per Share---0.480-0.4800%2.492-119%0.401-220%0.401-220%
Usd Price Per Share15.912-18%18.80318.8030%10.326+82%5.826+223%5.826+223%
Usd Profit---12585215.100-12585215.1000%-7765900.500-38%-7305054.900-42%-7305054.900-42%
Usd Revenue--3365042.4003365042.4000%190207.500+1669%796915.080+322%796915.080+322%
Usd Total Gains Per Share---0.427-0.4270%2.688-116%0.373-214%0.373-214%
 EOD+3 -2MRQTTM+0 -0YOY+8 -315Y+14 -2510Y+14 -25

3.2. Fundamental Score

Let's check the fundamental score of Hyloris Developmentsen Sa based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-35.403
Price to Book Ratio (EOD)Between0-18.530
Net Profit Margin (MRQ)Greater than0-3.740
Operating Margin (MRQ)Greater than0-3.464
Quick Ratio (MRQ)Greater than13.564
Current Ratio (MRQ)Greater than13.603
Debt to Asset Ratio (MRQ)Less than10.243
Debt to Equity Ratio (MRQ)Less than10.320
Return on Equity (MRQ)Greater than0.15-0.241
Return on Assets (MRQ)Greater than0.05-0.183
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Hyloris Developmentsen Sa based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.070
Ma 20Greater thanMa 5012.680
Ma 50Greater thanMa 10012.894
Ma 100Greater thanMa 20013.011
OpenGreater thanClose14.480
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets63,444
Total Liabilities15,388
Total Stockholder Equity48,056
 As reported
Total Liabilities 15,388
Total Stockholder Equity+ 48,056
Total Assets = 63,444

Assets

Total Assets63,444
Total Current Assets53,959
Long-term Assets53,959
Total Current Assets
Cash And Cash Equivalents 50,012
Short-term Investments 528
Net Receivables 2,321
Total Current Assets  (as reported)53,959
Total Current Assets  (calculated)52,861
+/- 1,098
Long-term Assets
Property Plant Equipment 295
Intangible Assets 2,944
Other Assets 3,257
Long-term Assets  (as reported)9,485
Long-term Assets  (calculated)6,496
+/- 2,989

Liabilities & Shareholders' Equity

Total Current Liabilities14,978
Long-term Liabilities410
Total Stockholder Equity48,056
Total Current Liabilities
Short-term Debt 11,880
Short Long Term Debt 11,815
Accounts payable 2,622
Other Current Liabilities 127
Total Current Liabilities  (as reported)14,978
Total Current Liabilities  (calculated)26,444
+/- 11,466
Long-term Liabilities
Capital Lease Obligations 174
Other Liabilities 301
Long-term Liabilities  (as reported)410
Long-term Liabilities  (calculated)475
+/- 65
Total Stockholder Equity
Common Stock129
Retained Earnings -54,805
Other Stockholders Equity 102,732
Total Stockholder Equity (as reported)48,056
Total Stockholder Equity (calculated)48,056
+/-0
Other
Capital Stock129
Cash and Short Term Investments 50,540
Common Stock Shares Outstanding 25,833
Liabilities and Stockholders Equity 63,444
Net Debt -37,723
Net Invested Capital 60,171
Net Tangible Assets 46,202
Net Working Capital 38,981
Short Long Term Debt Total 12,289



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
1,345
4,365
7,948
5,984
69,182
63,444
63,44469,1825,9847,9484,3651,345
   > Total Current Assets 
285
502
3,837
3,739
66,613
53,959
53,95966,6133,7393,837502285
       Cash And Cash Equivalents 
224
271
2,687
205
64,399
50,012
50,01264,3992052,687271224
       Short-term Investments 
13
10
0
0
7
528
5287001013
       Net Receivables 
20
216
1,141
333
253
2,321
2,3212533331,14121620
       Other Current Assets 
48
221
1,150
3,534
2,207
3,419
3,4192,2073,5341,15022148
   > Long-term Assets 
1,060
3,863
4,111
2,245
2,569
9,485
9,4852,5692,2454,1113,8631,060
       Property Plant Equipment 
57
35
149
98
176
295
295176981493557
       Intangible Assets 
0
3,825
3,949
2,138
2,381
2,944
2,9442,3812,1383,9493,8250
       Long-term Assets Other 
13
10
13
9
7
2,242
2,24279131013
> Total Liabilities 
3,533
8,651
12,410
16,171
10,123
15,388
15,38810,12316,17112,4108,6513,533
   > Total Current Liabilities 
1,062
1,870
3,101
16,149
2,132
14,978
14,9782,13216,1493,1011,8701,062
       Short-term Debt 
21
20
52
13,174
455
11,880
11,88045513,174522021
       Short Long Term Debt 
0
0
0
12,721
409
11,815
11,81540912,721000
       Accounts payable 
976
1,770
2,056
2,866
1,595
2,622
2,6221,5952,8662,0561,770976
       Other Current Liabilities 
65
80
942
62
35
127
12735629428065
   > Long-term Liabilities 
2,471
6,781
9,309
22
7,991
410
4107,991229,3096,7812,471
       Long term Debt Total 
0
15
66
22
0
0
002266150
       Long term Debt 
2,436
6,766
9,243
0
7,885
300
3007,88509,2436,7662,436
       Capital Lease Obligations Min Short Term Debt
35
15
66
-13,108
-303
-11,706
-11,706-303-13,108661535
       Other Liabilities 
0
-1
1
0
0
301
301001-10
       Long-term Liabilities Other 
0
0
0
0
0
1
100000
       Deferred Long Term Liability 
0
245
245
712
872
1,090
1,0908727122452450
> Total Stockholder Equity
-2,188
-4,286
-2,246
-10,188
59,059
48,056
48,05659,059-10,188-2,246-4,286-2,188
   Common Stock
67
79
89
89
129
129
12912989897967
   Retained Earnings -54,805-43,226-36,081-28,097-24,324-20,669
   Capital Surplus 
0
18,243
23,982
23,982
0
0
0023,98223,98218,2430
   Treasury Stock000000
   Other Stockholders Equity 
18,414
19,999
25,818
25,913
102,156
102,732
102,732102,15625,91325,81819,99918,414



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue3,096
Cost of Revenue-107
Gross Profit2,9892,989
 
Operating Income (+$)
Gross Profit2,989
Operating Expense-13,337
Operating Income-10,541-10,348
 
Operating Expense (+$)
Research Development5,056
Selling General Administrative2,900
Selling And Marketing Expenses-
Operating Expense13,3377,956
 
Net Interest Income (+$)
Interest Income32
Interest Expense-556
Net Interest Income-550-524
 
Pretax Income (+$)
Operating Income-10,541
Net Interest Income-550
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-11,282-9,800
EBIT - interestExpense = -11,282
-11,282
-11,023
Interest Expense556
Earnings Before Interest and Taxes (ebit)-10,726-10,726
Earnings Before Interest and Taxes (ebitda)-10,589
 
After tax Income (+$)
Income Before Tax-11,282
Tax Provision-297
Net Income From Continuing Ops-11,579-11,579
Net Income-11,579
Net Income Applicable To Common Shares-11,579
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses13,444
Total Other Income/Expenses Net-741550
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
2 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
2 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
2 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
3 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart